Mariana Oncology

Actithera Group

This company develops radioligand therapies to treat cancer patients by delivering radiation directly to solid tumours while sparing healthy tissue.

Alpha-9 Oncology

The company develops radiopharmaceutical therapies for patients with solid and haematologic malignancies.

Actithera

This biotechnology company develops targeted radioligand therapies to treat cancer patients by delivering radioactive isotopes directly to solid tumours.

Aktis Oncology

This biotechnology company develops alpha-emitting radiopharmaceuticals to treat patients with solid tumor cancers.

Alpha-9 Theranostics

This clinical-stage biotechnology company develops targeted radiopharmaceuticals to treat cancer patients by delivering radiation directly to tumours while sparing healthy tissue.

iOnctura

The company develops precision small-molecule medicines to treat patients with neglected and hard-to-treat solid tumours and cancers.

IDEAYA Biosciences

This precision medicine company develops targeted oncology therapeutics for patients with solid tumours and molecularly defined cancers.

Artbio

This company develops alpha radioligand therapies and manufacturing infrastructure to treat patients with prostate cancer and other solid tumours.